Без категории

State review boards take on drug prices amid Congressional inaction

How are states tackling high drug prices and increasing affordability? Clarivate market access expert Stephanie Hoops discusses the emergence of affordability review boards. Done waiting for Congress to take action on drug prices, states are increasingly enacting laws that create drug affordability review boards. As is done with utilities or insurance premiums, the boards allow states […]

Patient advocates speak out on partnering with life science companies

What does patient centricity mean from a patient’s point of view, and what kind of support do patient advocates need from life science companies? Three prominent patient advocates shared their perspectives. In 2010, Nick Sireau, a London-based father of two boys with the rare progressive genetic disease alkaptonuria (or AKU, also known as “Black bone […]

Best practices hospitals can adopt during vendor standardization: Q&A with Lori Goucher

In this interview, Lori Goucher, system clinical value analysis manager at Intermountain Healthcare, discusses best practices and success drivers in hospital vendor standardization.  The first step in reducing product variation and standardizing vendors is to define a strategy based on industry best practices and internal business intelligence. By pulling data from the organization’s multiple information […]

COVID-19 vaccines: Social media user sentiments and strategies to encourage administration

Although the pandemic continues to influence lives around the world, recent advances in vaccine development and distribution offer hope for relief. However, there is still uncertainty and misinformation surrounding the efficacy and safety of the vaccines. Clarivate experts Shubhita Thukraal and Vyshnavi Manda uncover consumer and healthcare worker attitudes based on analysis of social media […]

Immuno-oncology breakthroughs: from precision medicine to modulating the tumor microenvironment

The European Association for Cancer Research (EACR) explores the most exciting cancer research from Europe and globally. Clarivate Life Sciences Editor Joan Tur reviews the top three trends from their recent immuno-oncology event, and their implications for the future of cancer treatment. Despite pandemic-driven clinical trial delays across multiple therapy areas, novel immuno-oncology approaches continue […]

The unmet need for precision medicine in Lyme disease

Lyme disease cases and complications are rising, yet current treatment regimens are proving to be insufficient. Clarivate Senior Science Editor Shyama Ghosh and Managing Editor Stephen DuPraw collaborated with Principal Epidemiologist Swarali Tadwalkar to review the current and emerging treatment landscape and what’s needed to better serve patients.   In the U.S., about 30 million […]

Mainland China’s anticipated biosimilar boom – potential and key drivers of the market

The market of major biologics in Mainland China has tripled since 2017, with the potential to grow five-fold over the next ten years – which could drive biosimilars growth. Clarivate expert Akash Saini discusses this market’s potential and key drivers.    The approval of Shanghai Henlius Biotech’s HLX01—a biosimilar of rituximab (Roche’s MabThera)—in February 2019 […]

Retail giant Walmart enters the U.S. health insurance sector with Medicare plan play

Big box behemoth Walmart is getting into the U.S. market for health insurance with a pilot effort in Georgia. If successful, it could offer coverage to millions of American seniors and would represent the latest example of a chimeric healthcare offering covering payment, provision and distribution. Clarivate market access analysts Parvathy Menon and Sayantani Biswas […]